N/A
N=136
COVID-19 Project ECHO in Nursing Homes
Covid19
Bottom Line
View on ClinicalTrials.gov: NCT04499391 ↗Enrolled (actual)
136
Serious AEs
—
Results posted
Aug 2024
Primary outcome: Primary: Infection Rate — 141.91; 106.57; 1.54; 2.86 infections per 1,000 residents in 4 week
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Project ECHO (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Milton S. Hershey Medical Center
- Primary completion
- Sep 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Infection Rate |
141.91; 106.57; 1.54; 2.86; 2.08; 0.83 | — |
| SECONDARY Hospitalization |
40.05; 39.12; 3.09; 4.72; 5.55; 5.18 | — |
| SECONDARY Death |
30.22; 31.98; 0.82; 0.00; 0.46; 0.30 | — |
| SECONDARY Flu-like Illness |
0.65; 0.00; 0.00; 0.00; 0.00; 0.62 | — |
Summary
Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidence-based telehealth model, to connect Penn State University experts with remote nursing home staff and administrators to proactively support evidence-based infection control guideline implementation. Our study seeks to answer the critical research question of how evidence-based infection control guidelines can be implemented effectively in nursing homes
Eligibility Criteria
Inclusion Criteria for Facilities Skilled Nursing Facility in United States Access to computer or electronic device
Exclusion Criteria for Facilities Previously participated in Project ECHO COVID-19 series either through Penn State or another institution
Data sourced from ClinicalTrials.gov (NCT04499391). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.